Tehran University of Medical Sciences

Science Communicator Platform

Share By
Existing Antiviral Options Against Sars-Cov-2 Replication in Covid-19 Patients Publisher Pubmed

Summary: How can we quickly combat COVID-19? Review identifies promising broad-spectrum antiviral repurposing options targeting virus functions, a vital strategy for immediate response! #COVID19 #AntiviralDrugs

Ghanbari R1 ; Teimoori A2 ; Sadeghi A1 ; Mohamadkhani A1 ; Rezasoltani S3 ; Asadi E4 ; Jouyban A5 ; Sumner SCJ6
Authors

Source: Future Microbiology Published:2020


Abstract

COVID-19 caused by SARS-CoV-2, is an international concern. This infection requires urgent efforts to develop new antiviral compounds. To date, no specific drug in controlling this disease has been identified. Developing the new treatment is usually time consuming, therefore using the repurposing broad-spectrum antiviral drugs could be an effective strategy to respond immediately. In this review, a number of broad-spectrum antivirals with potential efficacy to inhibit the virus replication via targeting the virus spike protein (S protein), RNA-dependent RNA polymerase (RdRp), 3-chymotrypsin-like protease (3CLpro) and papain-like protease (PLpro) that are critical in the pathogenesis and life cycle of coronavirus, have been evaluated as possible treatment options against SARS-CoV-2 in COVID-19 patients. © 2021 Future Medicine Ltd
Other Related Docs
4. Therapeutic Potentials and Candidates for Covid-19, Iranian Journal of Science (2023)
5. Covid-19: A Review on Treatment Strategies and Candidate Vaccines, Scientific Journal of Kurdistan University of Medical Sciences (2021)
8. Therapeutic Strategies for Covid-19 Patients: An Update, Infectious Disorders - Drug Targets (2022)
10. Potential Role of Interferons in Treating Covid-19 Patients, International Immunopharmacology (2021)
11. Antiviral Optical Techniques As a Possible Novel Approach to Covid-19 Treatment, Journal of Innovative Optical Health Sciences (2021)
12. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
17. Prophylaxis With Chloroquine and Hydroxychloroquine in Covid-19, Journal of Iranian Medical Council (2020)